Bajaj Auto extends CEO's tenure, plans major investment

Several stocks are expected to be in the spotlight today. Bajaj Auto has announced that Rajivnayan Rahulkumar Bajaj will continue as Managing Director and CEO for an additional five years starting April 1. The company also plans to invest up to ₹ 1,500 crore in its subsidiary, Bajaj Auto Credit. Hero MotoCorp has formed a joint venture with Germany's Schmiedetechnik Plettenberg to produce parts for powertrains in India. This will help expand their market reach internationally. Dr. Reddy's Laboratories received final approval from the U.S. FDA for its 60 mg Apalutamide tablets, used to treat a specific type of prostate cancer. This product has significant sales potential in the U.S. Larsen & Toubro is set to hold a board meeting on March 27 to explore fundraising options, including possible debt issuance. Bharti Airtel's shareholders have approved the sale of its passive infrastructure assets to Indus Towers through online voting. G R Infraprojects has received a ₹ 4,262.78 crore project from the National Highways Authority of India. On another note, Hindustan Zinc has been fined for not meeting the required number of independent directors. Life Insurance Corporation of India (LIC) is in talks to acquire a stake in a health insurance company but has not finalized any agreements. Finally, Dr. Reddy's and Alvotech's BLA for a biosimilar product has been accepted by the FDA. In an effort towards sustainable aviation, Bharat Petroleum has signed a deal to develop a hydrogen-fueled aircraft ecosystem. This information serves as a market update, and investors should consult with experts before making investment decisions.